CDI Laboratories Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Employees
  • 25
Employees
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $2.1M
Latest Deal Amount
  • Investors
  • 6

CDI Laboratories General Information

Description

Operator of a proteomics company intended to address the critical needs required in order to accelerate research, advance discoveries and translate these discoveries into novel products and services that improve human health. The company combines vast proteomic libraries with deep expertise in synthetic biology to create Monomabs, a proteome-validated monospecific monoclonal antibodies and Antygen, a multi-dimensional immune profiling service, enabling clients to accelerate genomic research in academia and pharmaceutical companies.

Contact Information

Website
www.cdi.bio
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Primary Office
  • P.O. Box 569
  • Mayaguez, PR 00681
  • United States
+1 (939) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CDI Laboratories Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Angel (individual) 15-Jan-2021 $2.1M 00.000 Completed Generating Revenue
6. Grant 00.000 00.000 Completed Generating Revenue
5. Debt - General 00.000 Completed Generating Revenue
4. Angel (individual) 30-Jun-2015 00.000 00.000 0000 Completed Generating Revenue
3. Grant 26-Jun-2012 000.00 Completed Startup
2. Grant 01-Jan-2010 $471K Completed Startup
1. Accelerator/Incubator $900K Completed Startup
To view CDI Laboratories’s complete valuation and funding history, request access »

CDI Laboratories Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a proteomics company intended to address the critical needs required in order to accelerate research, advanc
Biotechnology
Mayaguez, PR
25 As of 2021
00.000
0000000000 00.000

00000000

tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitat
0000000000000
Seattle, WA
000 As of 0000
00000
0.000 0000-00-00
00000000 00000

00000000

bore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi
0000000000000
Norcross, GA
000 As of 0000
000000000 -
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CDI Laboratories Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Adaptive Biotechnologies Formerly VC-backed Seattle, WA 000 00000 00000000 00000
0000000000 Corporation Norcross, GA 000 000000000 -
00000 00000000000 Formerly PE-Backed Littleton, CO 00 000000&0
000000000 Private Equity-Backed Billerica, MA 00 00.00 000000000000 00.00
000000000 Formerly VC-backed Nottingham, United Kingdom 00 00000 000000 - 000
You’re viewing 5 of 5 competitors. Get the full list »

CDI Laboratories Patents

CDI Laboratories Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210333275-A1 Pan-isotype immunoglobulin fingerprinting Pending 23-Mar-2020 0000000000
EP-3497123-A1 Compositions and methods for analyzing nucleic acids associated with an analyte Withdrawn 12-Aug-2016 0000000000
US-20190169689-A1 Compositions and methods for analyzing nucleic acids associated with an analyte Pending 12-Aug-2016 0000000000
US-20170212101-A1 Methods and compositions to identify, quantify, and characterize target analytes and binding moieties Abandoned 18-Jul-2014 00000000000
EP-3169812-A1 Methods and compositions to identify, quantify, and characterize target analytes and binding moieties Withdrawn 18-Jul-2014 G01N33/5308
To view CDI Laboratories’s complete patent history, request access »

CDI Laboratories Executive Team (4)

Name Title Board Seat Contact Info
Ignacio Pino Lopez-Castro Co-Founder, President, Chief Executive Officer & Board Member
Daniel Eichinger Ph.D Co-Founder, Chief Scientific Officer & Board Member
Jef Boeke Ph.D Co-Founder & Board Member
Joseph Bonaventura Ph.D Co-Founder & Board Member
To view CDI Laboratories’s complete executive team members history, request access »

CDI Laboratories Board Members (7)

Name Representing Role Since
Antoine de Marsily Self Board Member 000 0000
Daniel Eichinger Ph.D CDI Laboratories Co-Founder, Chief Scientific Officer & Board Member 000 0000
Ignacio Pino Lopez-Castro CDI Laboratories Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Jef Boeke Ph.D CDI Laboratories Co-Founder & Board Member 000 0000
Jon Brennan-Badal CDI Laboratories Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

CDI Laboratories Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CDI Laboratories Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
Puerto Rico Industrial Development Company Other 000 0000 000000 0
Science, Technology and Research Trust Other 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »